phv02
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 10, 2022 (NCT05178901)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Nipah virusImmunity, active
Nipah virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06221813 | Phase 1 | Jan 26, 2024 | Coalition for Epidemic Preparedness Innovations, Public Health Vaccines LLC |
| NCT05178901 | Phase 1 | Jan 10, 2022 | Coalition for Epidemic Preparedness Innovations, Johnson County Clin-Trials, Public Health Vaccines LLC |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Academic/Hospital | 2 | 0 | 1 | 2022 |
| Public Health Vaccines LLC | For profit | 2 | 2 | 1 | 2022 |
| Johnson County Clin-Trials | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1